227 related articles for article (PubMed ID: 34181324)
21. An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.
R K; Chandra A; Jain T; Singh N; Agrawal R
Arch Oral Biol; 2024 Jun; 162():105944. PubMed ID: 38492547
[TBL] [Abstract][Full Text] [Related]
22. Assessment of serum copper, iron and immune complexes in potentially malignant disorders and oral cancer.
Tiwari R; David CM; Mahesh DR; Sambargi U; Rashmi KJ; Benakanal P
Braz Oral Res; 2016 Oct; 30(1):e101. PubMed ID: 27737355
[TBL] [Abstract][Full Text] [Related]
23. Exploratory Study to Evaluate Changes in Serum Lipid Levels as Early Diagnostic and/or Prognostic Indicators for Oral Submucous Fibrosis and Cancer among Gutkha Consumers in India.
Agarwal A; Tijare M; Saxena A; Rubens M; Ahuja R
Asian Pac J Cancer Prev; 2015; 16(15):6439-44. PubMed ID: 26434856
[TBL] [Abstract][Full Text] [Related]
24. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.
Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S
Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608
[TBL] [Abstract][Full Text] [Related]
25. Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders.
Uma Maheswari TN; Nivedhitha MS; Ramani P
Braz Oral Res; 2020; 34():e002. PubMed ID: 32049107
[TBL] [Abstract][Full Text] [Related]
26. Turmeric in the management of oral submucous fibrosis: A systematic review and meta-analysis.
Rai A; Kumar N; Sharma S; Parveen S; Rasheed A
J Cancer Res Ther; 2021; 17(2):327-335. PubMed ID: 34121673
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
28. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant treatments in patients with oral submucous fibrosis: A systematic review.
Pérez-Leal M; Lanciano F; Flacco N; Estornut C; Carceller MC
J Oral Pathol Med; 2024 Jan; 53(1):31-41. PubMed ID: 38155549
[TBL] [Abstract][Full Text] [Related]
30. Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without.
Chaturvedi P; Malik A; Nair D; Nair S; Mishra A; Garg A; Vaishampayan S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):225-230. PubMed ID: 28606826
[TBL] [Abstract][Full Text] [Related]
31. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
32. The Association between ABO Blood Group and the Risk of Colorectal Cancer: A Systematic Literature Review and Meta-Analysis.
Bahardoust M; Barahman G; Baghaei A; Ghadimi P; Asadi Shahir MH; Najafi Kandovan M; Tizmaghz A; Olamaeian F; Tayebi A
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2555-2563. PubMed ID: 37642040
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
34. Insight on the relationship of ABO blood grouping associated with oral premalignant lesions, conditions and inherited oral cancer syndromes.
Shishodia NP; Anekar J; Raj AC; Jhugroo C; Divakar DD; Alshehri SZ; Alkalib Mana Ali M
J Exp Ther Oncol; 2019 Jan; 13(1):59-63. PubMed ID: 30658029
[TBL] [Abstract][Full Text] [Related]
35. The secretor status of blood group antigens in the saliva in people with oral cancers: a systematic review.
Walpola T; Jayawardene KLTD; Weerasekara I
Syst Rev; 2024 Jan; 13(1):13. PubMed ID: 38167167
[TBL] [Abstract][Full Text] [Related]
36. Expression of lectin binding in oral submucous fibrosis.
Beena VT; Anil S; Remani P; Vijayakumar T
Indian J Dent Res; 1998; 9(3):85-90. PubMed ID: 10530194
[TBL] [Abstract][Full Text] [Related]
37. A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis.
Saso L; Reza A; Ng E; Nguyen K; Lin S; Zhang P; Fantozzi PJ; Armagan G; Romeo U; Cirillo N
Antioxidants (Basel); 2022 Apr; 11(5):. PubMed ID: 35624733
[TBL] [Abstract][Full Text] [Related]
38. Analysis of salivary secretor status in patients with oral submucous fibrosis: a case-control study.
Hallikeri K; Udupa R; Guttal K; Naikmasur V
J Investig Clin Dent; 2015 Nov; 6(4):261-6. PubMed ID: 24850779
[TBL] [Abstract][Full Text] [Related]
39. Socio-Economic Implications Of A Younger Aged Female Predilection In Malignant Transformation Of Oral Sub Mucous Fibrosis.
Fatima N; Mohiuddin S; Hosein S; Mervyn M
J Ayub Med Coll Abbottabad; 2019; 31(1):16-20. PubMed ID: 30868776
[TBL] [Abstract][Full Text] [Related]
40. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
